SELLAS Life Sciences Group, Inc. (SLS) Tops Q2 EPS by 4c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q2 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• TJX stock drops as profit outlook falls short of analyst estimates
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance